Expert thinking on productivity, intangible asset valuation, growth strategy, and building more valuable businesses.
Venture capital investment decisions are intangible asset decisions. Every VC who writes a cheque is betting on the quality and growth trajectory of a startup's technology, team, IP, customer capital, and brand. Understanding how they evaluate these assets gives founders a strategic advantage.
Read more →
A complete step-by-step guide to calculating intangible asset values using the Multi-Period Excess Earnings Method (MPEEM). Includes a worked numerical example with contributory asset charges, tax adjustments, and present value calculations.
Read more →
Companies track physical capital expenditure meticulously. Intangible investments — often larger and more strategically important — are buried in operating expenses and forgotten. Opagio's investment tracking changes this by monitoring intangible capex over time and connecting it to measurable productivity outcomes.
Read more →
A complete guide to the free Opagio Intangibles Questionnaire: 36 anchored questions across six categories of intangible investment, a 0-100 score for each, and a report that shows where to invest next.
Read more →
Technical debt is the mirror image of technology capital. Where well-architected code creates an appreciating intangible asset, accumulated shortcuts create a depreciating one. Understanding technical debt as a negative intangible asset changes how founders and investors measure technology value.
Read more →
GDP and TFP miss AI-driven productivity because they were built for tangible capital. Why national measurement frameworks must evolve for the AI age.
Read more →
Royalty rate benchmarking turns comparable licences into a defensible rate. The steps, the sources, the interquartile range, the cross-checks that replaced the 25% rule, and a worked example from eight comparables to a relief from royalty value.
Read more →
Most board packs report revenue, burn rate, and runway. They ignore the intangible assets that generate much of the company's value. Adding intangible asset KPIs to board reporting transforms the quality of strategic decisions and the depth of investor engagement.
Read more →
Healthcare and MedTech companies invest billions in clinical evidence, regulatory approvals, and proprietary health data — assets that represent formidable barriers to competition and durable sources of revenue. Yet these assets remain largely invisible to the lending market. Here is how structured intangible collateral can transform healthcare financing.
Read more →
IAS 38 hasn't kept pace with the intangible economy. See what IASB, CSRD and FRC updates mean for SMEs preparing for exit or investor reporting in 2026.
Read more →
Revenue-based financing offers startups non-dilutive capital tied to revenue performance. Equity financing offers larger sums but permanent dilution. The right choice depends on which intangible assets you are building — and whether those assets benefit more from capital preservation or capital scale.
Read more →
How to value in-process research and development (IPR&D) in purchase price allocations under IFRS 3 and ASC 805. Covers probability-adjusted cash flow modelling, completion risk assessment, and the critical accounting differences between standards.
Read more →Get the latest insights on intangible asset growth and productivity delivered to your inbox.
Take the free intangible asset assessment and discover where your biggest growth opportunities lie.